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Abstract 
 
 Hcm1 is a cell cycle-regulatory transcription factor in budding yeast, which activates 
several mitotic spindle regulatory genes. Its human homolog, FoxM1, is overexpressed in a 
number of human cancers. Preliminary data indicates that Cdk1 phosphorylation is required for 
Hcm1 activity but the consequences of this phosphorylation at the molecular level are not well 
understood. I developed a screen to identify the specific Cdk phosphorylation sites that are 
important for Hcm1 function, in order to understand how phosphorylation stimulates its activity. 
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1. Introduction 
 
 Cell division is a fundamental process that drives development and reproduction, but its 
misregulation can cause a number of diseases, including cancer.  The cell cycle is the process by 
which cells divide and replicate their DNA through a series of phases (G1, S, G2, and M) that 
must occur in the proper order.  The cycle begins with a gap phase (G1) allowing for growth and 
control. Entry into S-phase is a critical regulatory transition, in that the cell commits to division 
or decides to exit the cycle, depending on nutrient availability and/or growth factor signaling.  
During S-phase DNA is replicated and chromosomes are duplicated.  A second gap-phase, G2, 
occurs after S-phase to ensure that all genes necessary for the next part of the cycle are properly 
transcribed and that replication genes are turned off to prevent further DNA replication.  Mitosis 
and cytokinesis, which comprise M phase, follow G2.  It is in mitosis that the newly duplicated 
chromosomes are segregated into a pair of daughter nuclei and the cell divides itself into two 
daughter cells in cytokinesis (Morgan, 2007).  Figure 1 details the events of the eukaryotic cell 
cycle.  Control and regulation of the cycle is extremely important, as it enables cells to divide 
only when they receive the necessary signals. When cell cycle is misregulated, excessive cell 
proliferation can occur, leading to malignancies and many types of cancers.  Ultimately, 
understanding the mechanisms of cell-cycle control will provide crucial information as to what 
goes wrong in cancer cells.  
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Figure 1: Stages of the eukaryotic cell cycle (Morgan, 2007). 
 
 The process of cell division and cell-cycle control is highly conserved among all 
eukaryotes.  Saccharomyces cerevisiae, a single-celled eukaryote, is an excellent model 
organism for studying the cycle, and it was in budding yeast that many cell cycle genes were first 
identified (Hartwell et al., 1974).  As a single-celled organism, the stages of the cell cycle can be 
easily visualized from the appearance and size of the budding cell.  Additionally, the yeast 
genome has been fully sequenced and can be easily manipulated for genetic analysis (Morgan, 
2007).   
 Of the 6,000 genes comprising the yeast genome, the transcription of about 1000 genes is 
cell cycle-regulated (Pramilla, 2006; Spellman, 1998; Cho, 1998).  In combination with regulated 
protein degradation, cyclical transcription helps to ensure that proteins are expressed only when 
they are needed and are eliminated after their function is complete.  This coordinated and 
periodic expression ensures that cell-cycle events happen unidirectionally and in the proper order.  
Different gene clusters peak in the different phases of the cycle, and this cell cycle-regulated 
transcription is controlled by cyclin dependent kinases (Cdks) (Dynlacht, 1997). 
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 Cyclin-dependent kinases are serine/threonine protein kinases that coordinate all cell-
cycle events.  Budding yeast have only one, Cdk1, where humans have four, Cdk1, 2, 4 and 6, 
which are active in different phases of the cell cycle.  Each Cdk pairs with a cyclin to 
phosphorylate its targets at serine/threonine residues.  Binding to a cyclin exposes the active site 
of the Cdk and directs it to a particular set of targets.  In yeast, despite there being only one Cdk, 
there are 9 cyclins that bind sequentially throughout the cell cycle.  The particular cyclin that 
binds the Cdk confers its specificity.  The G1 cyclin that is involved in cell growth and 
commitment to the cell cycle is Cln3.  Cln3/Cdk1 promotes expression of Cln1 and 2, which 
facilitate the G1/S transition.  Clb5 and 6 are expressed in S-phase and stimulate DNA 
replication.  In M-phase, Clb1, 2, 3, and 4 are necessary for spindle formation along with 
chromosome alignment and segregation (Bloom and Cross, 2007).  The activity of Cdks is thus 
required for progress through cell-cycle transitions (G1/S and G2/M), and their activity must be 
extinguished for cells to complete mitosis.  Cdk1 targets hundreds of proteins (Ubersax et al., 
2003, Holt et al., 2009) and can either directly affect their activities, or stimulate or inhibit 
protein degradation.  The main targets of Cdks include cell-cycle regulators and transcription 
factors that drive expression of cell cycle-regulated genes. 
 Cell cycle-regulated transcription, in yeast and mammals, is controlled by cyclin/Cdk 
complexes (Dynlacht, 1997).  Of the waves of gene expression that are cell cycle-regulated, the 
G1/S cluster is the best characterized and is responsible for the progression into S-phase and the 
initiation of events for a new cell cycle.  It is also the largest, comprising more than 200 genes 
(Haase and Wittenberg, 2014).  The expression of the genes in this cluster in yeast is stimulated 
by Cln3/Cdk1, which phosphorylates and inactivates the transcriptional repressor, Whi5.  This 
then leads to the activation of the transcriptional activators, SCB-binding factor (SBF) and MCB-
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binding factor (MBF) (van den Heuval & Dyson, 2008; Costanzo et al., 2004; de Bruin et al., 
2004).  These activators are then phosphorylated by Cdk late in S-phase, which inhibits their 
functions (Bertoli et al., 2013).  The G2/M gene cluster is also relatively well-characterized and 
is comprised of about 35 genes.  The Fkh2 transcription factor when bound to its co-activator 
Ndd1 and the MADS protein Mcm1 are the primary regulators of the G2/M gene cluster and 
facilitate the G2/M transition (Haase and Wittenberg, 2014).  Fkh2 and Ndd1 are also 
phosphorylated by Cdk, which fosters their interaction and recruits them to their target promoters 
(Pic-Taylor et al., 2004; Reynolds, 2003).  Unlike the G1/S and G2/M waves of gene expression, 
little is known about how expression of S-phase genes may be regulated by Cdk1. 
 S-phase genes are regulated by the transcription factor Hcm1, which is one of four 
forkhead transcription factors in yeast that contain a winged helix DNA-binding domain and are 
important for the regulation of a variety of cellular processes (Pramilla et al., 2006).  Hcm1 is a 
transcriptional activator that is expressed in late G1, but its targets peak in both early and late S-
phase.  It is estimated to regulate approximately 185 target genes that are involved in 
chromosome segregation, spindle fiber formation, and budding.  Additionally, its targets include 
downstream transcription factors that drive expression of other cell cycle-regulated gene clusters 
(Haase and Wittenberg, 2014).  For example, Hcm1 binds to and activates the transcriptional 
activators, Fkh1, Fkh2 and Ndd1, which are necessary for G2/M-phase gene expression.  Cells 
lacking Hcm1 (hcm1Δ) are viable, but show chromosome loss and require the spindle checkpoint 
for viability (Pramila et al., 2006).   
 Importantly, the human homologue of Hcm1, FoxM1, is overexpressed in a number of 
human cancers such as liver, prostate, brain, breast and colon cancer.  It is one of the most 
commonly upregulated genes in human tumors and its deregulation leads to cancer progression 
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and the development of cancer drug resistance (Koo et al., 2012). Like Hcm1, FoxM1 activates 
genes in G2-phase to help drive the G2/M transition and induce gene expression necessary for 
M-phase (Murakami et al., 2010).  Interestingly, Hcm1 activity is low during G1/S, due to an 
auto-inhibitory interaction between its amino and carboxy-terminal domains.  Cdk 
phosphorylation of the C-terminus of FoxM1 is required for its activation and reversing the auto-
inhibition.  FoxM1 contains 15 Cdk consensus sites, 12 of which are in its C-terminus and in its 
transactivation domain (TAD) (Anders et al., 2011).   Ultimately, a better understanding of 
FoxM1 will aid in the treatment of a large number of cancers, and studying the regulation of its 
homolog in yeast, Hcm1, provides a way to achieve this goal. 
1.1. Preliminary data 
 
  Similar to FoxM1, the Benanti lab has shown that Hcm1 is regulated by Cdk1 
phosphorylation (Landry et al., 2014).  Hcm1 contains 15 Cdk consensus sites: 3 in its N-
terminus, 4 in its interior, and 8 in its C-terminus, as shown in the diagram in Figure 2A.  When 
all 15 Cdk consensus sites (S/T-P motifs) of Hcm1 are mutated by changing the serine/threonines 
to non-phosphorylatable alanines, the mutant (Hcm1-15A) is more stable than the wild-type 
protein and is expressed at higher levels throughout the cell cycle (Figure 2B).  However, Hcm1 
target genes are also downregulated in cells expressing the Hcm1-15A (Figure 2C) (Landry et al., 
2014). Cdk-regulated degradation and activation of Hcm1 can be uncoupled by separately 
mutating the clusters of Cdk sites that are found in its N-terminus (Hcm1-3N mutant) and its C-
terminus (Hcm1-8C mutant) (Figure 2).  Hcm1-3N shows increased protein expression over the 
cell cycle, whereas the Hcm1-8C expressed at levels similar to wild-type Hcm1 (Figure 2D).  
This shows that the N-terminal Cdk sites are necessary for the degradation of Hcm1 (Landry et 
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al., 2014). Additionally, these data point to coordinated positive (activation) and negative 
(degradation) regulation of Hcm1 by Cdk1 phosphorylation.   
!
"# $#
%
 
Figure 2: Cdk1 regulates Hcm1 activation and degradation. 
(A) Diagram of the transcription factor Hcm1, detailing the Cdk consensus sites (S/T-P sites). 
(B) Expression of wild-type Hcm1 and Hcm1-15A over the cell cycle. Cells were arrested in G1, 
released into the cell cycle and samples were collected at 15-minute intervals. Protein levels 
were visualized by Western blotting. Cdk1 levels are shown as a loading control. (C) RT-qPCR 
data showing the expression of Hcm1 target genes in hcm1Δ and hcm1-15A cells relative to 
expression in wild-type cells. Cells were arrested in G1 and collected 45 minutes after release 
when cells were in late S-phase. (D) Phosphorylation of the N-terminus of Hcm1 promotes its 
degradation. Expression of Hcm1-3N and Hcm1-8C over the cell cycle. Cells were arrested in 
G1, released into the cell cycle and samples were collected at 15-minute intervals. Protein levels 
were visualized by Western blotting. Cdk1 levels are shown as a loading control Data are 
reproduced from Landry et al., 2014.  
 
 To determine which phosphorylation sites are required for Hcm1 function, mutants were 
then grown on plates containing the microtubule poison, benomyl, as the targets of Hcm1 are 
involved in regulating the mitotic spindle and cells lacking Hcm1 function are benomyl-sensitive 
(Horak et al., 2002; Daniel et al., 2006).  As shown in Figure 3, the Hcm1-8C mutant is sensitive 
to the poison and mimicked the growth of cells expressing the Cdk-deficient allele of Hcm1, 
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Hcm1-15A, and hcm1Δ cells.  Therefore, the 8 C-terminal Cdk consensus sites of Hcm1 are 
important for stimulating its activity (Landry et al., 2014).  This data is bolstered by the fact that 
cells expressing the Hcm1-8C mutant show decreased association with target gene promoters 
compared to wild-type Hcm1 (Landry et al., 2014).  From these data, we conclude that Cdk1 
phosphorylation of some or all of these C-terminal sites are required for Hcm1 activation.  
 
 
Figure 3: Phosphorylation of the C-terminus of Hcm1 stimulates its activity. 
5-fold dilutions of strains with the indicated genotypes on a rich medium plate (YPD) or a plate 
containing 15µg/mL of the spindle poison benomyl (reproduced from Landry et al., 2014). 
 
1.2. Hypothesis and Goals  
 
 The consequences of Hcm1 phosphorylation at the molecular level are not well 
understood. The goal of this project is to understand how phosphorylation of Hcm1 stimulates its 
activity.  I set out to test the hypothesis that Cdk1 phosphorylation of Hcm1 at one or more 
specific sites in its C-terminus is important for its recruitment to its target promoters, thus 
allowing for the correct and timely gene expression of Hcm1 target genes.  
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2. Results 
2.1. Mutagenesis 
 
 In order to investigate how Cdk1 phosphorylation of Hcm1 stimulates its activity, I first 
wanted to determine if specific Cdk consensus sites in its C-terminus are required for activation.  
However, since there are 11 Cdk consensus sites in the C-terminal half of Hcm1, it is not 
practical to generate every possible combination of mutations in these sites.  For this reason, I 
took a randomized approach, utilizing the property of homologous recombination in S. cerevisiae 
(Ma et al., 1987).  Homologous recombination enables the reconstruction of a plasmid in yeast, 
upon transformation with several fragments of DNA with overlapping sequences.  We developed 
a strategy in which we could use this approach to randomly recombine fragments of DNA 
containing either wild-type Hcm1 sequences and sequences with Hcm1 phosphosite mutations, 
which could then be screened to determine which of the resulting mutants were functional (see 
Figure 4). 
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Figure 4: Randomized mutagenesis strategy. 
Model detailing the mutagenesis conducted to randomly recombine 11 C-terminal phosphosites 
in Hcm1 using the principle of homologous recombination in yeast. Asterisk indicates mutated 
HCM1 generated by recombination. 
  
 First I constructed a plasmid in which the wild-type HCM1 gene with a C-terminal 
epitope tag was expressed from its endogenous promoter, as seen at the top of Figure 4.  I 
digested the plasmid and purified the linear fragment that lacked the sequence encoding the C-
terminus of Hcm1.  Next, I used PCR to amplify 6 overlapping sequences that contained either 
wild-type HCM1 sequence or HCM1 sequence with mutations changing the serine/threonine 
residues to non-phosphorylatable alanines (Figure 4; A-C are wild-type sequences, D-F are 
phosphomutant sequences).  All 6 fragments and the digested vector backbone were then co-
transformed into an hcm1Δ strain and cells containing the plasmid were selected for on plates 
lacking histidine (bottom of Figure 4).  An hcm1Δ background was used to determine if the 
different combinations of phosphosites received could rescue the benomyl-sensitivity of this 
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strain.  Since all 6 PCR products contained overlapping sequences, it was expected that they 
would recombine with the vector backbone in random combinations and generate a large number 
of unique HCM1 mutants. These mutants could them be assayed to gain insight into which sites 
in the C-terminus of Hcm1 are required for its activation by Cdk1.   
2.2. Primary Screen of Mutants 
 
  Hcm1 activates transcription of a number of genes that regulate the mitotic spindle. As a 
result, cells without functional Hcm1 are sensitive to drugs that interfere with microtubule 
polymerization and perturb spindle function (Pramila et al., 2002; Daniel et al., 2006). I took 
advantage of this sensitivity to develop a screen that was used to determine which Cdk consensus 
sites are important for Hcm1 function.  First, colonies from the transformation that grew on the 
selection plates were picked, as they were predicted to carry an intact plasmid with some 
combination of the 11 phosphosite mutations.  Of those selected, 94 colonies were screened on 
plates containing the spindle poison benomyl, and assayed for their ability to rescue the hcm1Δ 
phenotype. Isolates were compared to strains expressing wild-type Hcm1 from a plasmid, an 
empty vector control plasmid, or the Hcm1-8C mutant that we previously found conferred 
benomyl-sensitivity (Figure 3, Figure 5).  I then sequenced 18 plasmids that rescued benomyl-
sensitivity similar to wild-type Hcm1, and 18 plasmids that failed to rescue the benomyl-
sensitivity phenotype, so that I could draw conclusions as to which sites must be phosphorylated 
for the activation of Hcm1.  For example, if a collection of sites was mutated in a particular 
isolate and it was as sensitive as the hcm1Δ strain, this would suggest that these sites are 
necessary for Hcm1 function.  Conversely, if the phenotype of the mutant mimicked wild-type 
Hcm1-expressing cells, then this would indicate that phosphorylation of this cluster of sites is not 
required for Hcm1 activation.  
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Figure 5: Growth of the Hcm1 mutants expressed from plasmids on benomyl plates. 
5-fold dilutions of strains indicated in the key were spotted in three columns on a rich media 
plate (YPD) or plates containing 15µg/mL or 20µg/mL of the spindle poison benomyl. 
 
 Among the 36 colonies that I sequenced, 10 different combinations of the 11 C-terminal 
phosphosite mutations were obtained (Table 1).  Of these 10, 5 combinations were sensitive to 
benomyl, 4 were not, and 1 combination had mixed results (Figure 5).  Also, several 
combinations were isolated more than once. 
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Table 1: Combinations of phosphosite mutations isolated during mutagenesis and benomyl-
sensitivity screen. The mutants were named with a letter and “X” denotes whether the site was 
mutated for that particular isolate.  The sensitivity of the mutant to benomyl was compared to 
controls (WT, wild-type Hcm1; 11C and 8C, previously characterized, non-functional mutants) 
and the number of times a combination was received is denoted.  
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 In order to confirm that the mutations of the Cdk consensus sites of Hcm1 were not 
affecting the expression of the protein, levels were compared by Western blot (Figure 6).  
Consistent with our previous findings that mutation of the C-terminal sites did not affect Hcm1 
stability, all mutants were expressed at levels similar to wild-type Hcm1.  There was no Hcm1 
protein expressed by the hcm1Δ cells, as expected.   
 
 
Figure 6: Expression of Hcm1 mutants from plasmids.   
Western blot showing V5-tagged Hcm1 proteins, expressed from the plasmids described in Table 
1. Cdk1 levels are shown as a loading control.     
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 Although some differences were evident in the primary screen, biological replicates of 
some mutants showed inconsistent results using this screening technique.  One possible 
explanation for this variability is that strains could not be grown under conditions to select for 
the plasmid, since I found that benomyl was ineffective in synthetic drop out medium plates.  For 
this reason, the assay was carried out under non-selective conditions. This could possibly 
influence the plasmid copy number per cell, altering expression of Hcm1 (see more discussion 
below).  Therefore, in order to strengthen my conclusions as to which Cdk consensus sites in the 
C-terminus of Hcm1 are important for its function, I proceeded to integrate a few representative 
mutations isolated in the screen into the yeast genome.  
2.3. Integration of Mutants into the Genome 
 
 Combinations of the 11 Cdk consensus site mutations that I predicted would be 
informative were chosen to integrate in the genome (Table 2).  For the integration, I decided to 
focus on the cluster of 8 sites found at the C-terminus of the Hcm1 protein, since we previously 
found that mutation of just these sites conferred benomyl-sensitivity (Figure 2, Figure 3).  
Combinations A, D, E, J and G were selected from Table 1.  Plasmids A and D were selected 
because A contains mutations in the last 5 of the 8 phosphosites (T460, S471, T479, T486, S496), 
and D is the converse, containing mutations in only the first 3 of the 8 phosphosites (T428, T440, 
and T447).  Thus I predicted that looking at the growth and sensitivity of these mutants would 
indicate if those particular clusters of sites are important for the stimulation of Hcm1 activity.  
Additionally, plasmid A showed mixed results in the plasmid-based screen.   Plasmids E and J 
were selected because they differ in two phosphosites, T479 and T486, and thus screening these 
combinations could indicate the roles of those particular sites.  Finally, plasmid G was selected 
in that it contains a mutation in the last phosphosite, S496, only.  This group of combinations 
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also provides clusters of phosphosite mutations ranging from 5 to 1, which may suggest that an 
overall charge difference is necessary for the stimulation of Hcm1 activity, rather than specific 
sites.   
Five strains were constructed with these genotypes.  In order to do this, the desired sites 
were PCR amplified from the plasmids and then transformed into either wild-type HCM1 cells or 
hcm1-8C cells depending on the combination of C-terminal phosphosites desired (see Methods 
for more details). The strains created are referred to as Hcm1C-5A, Hcm1C-3A, Hcm1C-4A, 
Hcm1C-2A, and Hcm1C-1A, respectively (Table 2). 
Table 2: Strains expressing Hcm1 mutants from the genomic locus. The strain names are 
indicated and an “X” denotes whether the site was mutated for that particular strain. The 
behavior of the mutant on benomyl was characterized in comparison to the growth of controls.  
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 In order to ensure that the integration of the Cdk consensus site mutations did not affect 
the expression of the Hcm1 protein, levels were compared by Western blot (Figure 7).  The five 
strains were tested alongside wild-type Hcm1, hcm1Δ, Hcm1-15A, and Hcm1-8C cells as 
controls.  As expected, no protein was observed in hcm1Δ cells and increased expression of 
Hcm1-15A was observed, as the 3 N-terminal phosphosites that are required for its degradation 
are changed in this mutant (Landry et al., 2014). Importantly, all five unique Hcm1 mutants that I 
generated were expressed at similar levels to the wild-type Hcm1 and Hcm1-8C, confirming that 
mutation of these sites does not affect protein expression. 
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Figure 7: Expression of Hcm1 mutants integrated into the genome. 
Western blot showing Hcm1 and Cdk1 protein levels for the strains from Table 2. 
 
 Strains expressing phosphosite mutations from the genomic locus were then screened 
using the benomyl assay described above (Figure 8).  They were tested alongside wild-type 
HCM1, hcm1Δ, hcm1-15A, and hcm1-8C strains and their sensitivities compared (Table 2). I 
found that Hcm1C-5A, 3A- and 4A-expressing cells grew in a manner similar to the 
hcm1Δ mutants, whereas the Hcm1C-1A and 2A strains were substantially healthier and grew 
similar to wild-type HCM1 cells.  Biological replicates confirmed these results.  While this data 
does not yet point to specific sites as necessary for Hcm1 activation, it does demonstrate that 
only a subset of these 8 C-terminal sites are required for Hcm1 activation, and it suggests several 
possible models for how this phosphoregulation may work.    
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Figure 8: Benomyl-sensitivity of strains expressing Hcm1 phosphomutants from the 
genomic locus. 
5-fold dilutions of strains with the indicated genotypes were spotted in two columns on a rich 
media plate (YPD) or plates containing 15µg/mL or 20µg/mL of the spindle poison benomyl, 
with genotypes labeled to indicate the identity of the spots. 
 
3. Discussion 
3.1 Mutagenesis Approach and Benomyl Sensitivity Screen 
 
 Here, I used a novel approach to randomly recombine 11 phosphosite mutations in the C-
terminus of Hcm1, in order to generate a collection of unique combinations of mutations.  This 
randomized strategy proved to be extremely effective for the creation of Hcm1 phosphomutants 
with different combinations of these phosphosites.  As seen in Table 1, 10 unique combinations 
were constructed and screening more colonies from the original transformation could have led to 
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the identification of additional combinations. This method was more efficient than a site-directed 
approach as different combinations of the phosphosite mutations could be generated rapidly.   
 I then used a benomyl sensitivity screen to determine which Cdk consensus sites in the C-
terminus of Hcm1 are important for its function.  I performed a primary screen with the Hcm1 
mutants expressed from plasmids and assayed for their ability to rescue the sensitivity of an 
hcm1Δ strain, as compared to strains expressing wild-type Hcm1 from a plasmid, an empty 
vector control plasmid, or the Hcm1-8C mutant that we previously found was nonfunctional 
(Landry et al, 2014).  Although this screen led to some preliminary conclusions, biological 
replicates of some mutations gave inconsistent results using this screening approach (Table 1).  
One possible reason for this is that for cells to retain the plasmids, they must be grown in 
synthetic media lacking histidine. However, I found that benomyl was ineffective in synthetic 
media.  Therefore, cells were assayed on rich media plates containing benomyl and it is possible 
that they lost the plasmid and were no longer expressing Hcm1.  This expression pattern could 
vary each time I conducted the assay, which could account for the inconsistency.  Protein levels 
were approximately equal by Western blot for all plasmid strains (Figure 6), however, in contrast 
to the benomyl assay, cells were grown in selective media lacking histidine in this experiment.  
In order to draw better conclusions about the Hcm1 phosphomutants, we decided to integrate the 
informative combinations identified from the randomized mutagenesis into the genome and 
repeat the benomyl sensitivity assay with strains expressing Hcm1 mutants from the HCM1 locus. 
 When I performed the benomyl screen with the strains expressing the mutations from the 
genomic locus, the results were more conclusive.  Biological replicates showed consistent results 
each time the assay was performed.  Control strains grew as predicted on the benomyl plates 
further validating the screen.  Therefore, the randomized mutagenesis strategy was successful in 
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generating different combinations of phosphosite mutations in the C-terminus of Hcm1, and 
while the plasmid-based screen provided preliminary conclusions, the benomyl screen conducted 
with the strains expressing the Hcm1 mutants from the genomic locus enabled me to effectively 
investigate which Cdk phosphorylation sites are necessary for Hcm1 activation. 
3.2 Hcm1 Phosphoregulation 
 
 My data suggests two possible models for Hcm1 phosphoregulation: one possibility is the 
phosphorylation of two or more specific sites are required for Hcm1 activation, while the other 
implies an overall negative charge may be required (Figure 9).  
 
 
Figure 9: Possible Mechanisms of Hcm1 Phosphoregulation 
(A) Phosphorylation of more than one specific site may be required for the activation of Hcm1, 
for example T440 and T479, whereas phosphorylation of only 1 of these sites would be 
insufficient. (B) An overall negative charge of the C-terminus of Hcm1 is required. For example, 
phosphorylation of any combination of 5 sites may be sufficient. 
 
 As seen in Table 2 and Figure 8, the Hcm1C-5A and Hcm1C-3A strains were both 
sensitive to benomyl.  Hcm1C-5A contains mutations in the last 5 of the 8 phosphosites (T460, 
S471, T479, T486, S496), and Hcm1C-3A is the converse, containing mutations in only the first 
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3 of the 8 phosphosites (T428, T440, and T447).  Thus, one possibility is that phosphorylation at 
one or more sites in each of these mutated clusters may be required for Hcm1 activation.  For 
example, as suggested in Figure 9A, it is possible that both sites T440 and T479 are needed, but 
phosphorylation of only one of the two would be insufficient to recruit Hcm1 to its target 
promoters and promote timely gene expression.  In the Hcm1C-5A and Hcm1C-3A strains, one 
of these two sites is mutated in each, which could be why they were sensitive to benomyl.  Cdk 
phosphorylation of Ndd1, another transcriptional activator, provides an example of a 
transcription factor regulated by site-specific phosphorylation (Reynolds et al., 2003). 
Phosphorylation of Ndd1 on site T319 is required for its recruitment to target gene promoters 
and association with other binding factors.  Mutation of this phosphosite to a non-
phosphorylatable alanine significantly reduces the association of Ndd1 with its target promoters 
and impairs transcriptional regulation. 
 When I repeated the benomyl screen using strains that expressed the mutants from the 
genomic locus, the Hcm1C-5A, 3A and 4A expressing cells grew in a manner similar to the 
hcm1Δ mutants, as they were sensitive to benomyl.  In contrast, the Hcm1C-1A and 2A strains 
grew similar to wild-type HCM1 cells. These data suggest an alternative model in which an 
overall negative charge may be necessary for Hcm1 activation, rather than phosphorylation at 
specific sites.  The Hcm1C-1A and Hcm1C-2A contain fewer phosphosite mutations and thus 
more sites can be phosphorylated by Cdk.  This creates a greater overall negative charge on the 
C-terminus of Hcm1, which may be important for Hcm1 function and recruitment to target 
promoters.  Figure 9B presents this model of Hcm1 phosphoregulation.  In support of this model, 
multisite phosphorylation and thus overall charge have been found to be critical for regulation 
and degradation of other proteins.  For example, multisite phosphorylation of Ste5 (a scaffold 
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protein in yeast involved in mating) during G1 phase is required for its inhibition and the 
promotion of a new division cycle (Strickfaden et al., 2007).  Additionally, Sic1, which is a B-
type cyclin/CDK inhibitor, must be phosphorylated on at least 6 phosphosites for its inhibition 
and subsequent cell-cycle progression (Nash et al., 2001).   
 It is also possible that these models are not mutually exclusive.  Rather, the 
phosphorylation at two specific sites (such as T440 and T479) could be necessary for 
phosphorylation of additional sites in the C-terminus, creating an overall negative charge that 
stimulates Hcm1 activity.  Support for this combined model comes from what is known about 
FoxM1, the human homologue of Hcm1.  FoxM1 contains 15 Cdk consensus sites, 12 of which 
are in its C-terminus in its transactivation domain (TAD).  Phosphorylation of this TAD domain 
promotes FoxM1 activation and 3 specific Cdk consensus sites within the domain, T600, T611 
and S638, critically contribute to its function (Laoukili et al., 2008).  However, phosphorylation 
of these three sites is not sufficient for FoxM1 activation, as an additional 2 to 4 sites in the TAD 
are also required (Anders et al., 2011).  Therefore, these three sites could be required for the 
phosphorylation of the 2 to 4 other Cdk consensus sites, producing an overall negative charge in 
the TAD domain.  Due to the fact that Hcm1 is structurally and functionally similar to FoxM1, 
this proposed mechanism of Hcm1 phosphoregulation involving both specific sites and an 
overall charge is highly plausible. 
 In the future, we hope to use these mutants that I have constructed to better understand 
the molecular consequences of Hcm1 phosphoregulation and how phosphorylation actually 
promotes binding to its target genes.  One possibility is that Cdk phosphorylation may stimulate 
Hcm1 activity by promoting its interaction with another protein required for its binding to DNA. 
Cdk phosphorylation of the C-terminus of FoxM1 stimulates its binding to target promoters by 
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initiating interaction with the coactivator CREB-binding protein, whose role is to activate 
transcription (Chen et al., 2009).  Due to the fact that FoxM1 is the human homologue of Hcm1, 
it is possible that a similar interaction exists in yeast and the phosphorylation promotes the 
recruitment of Hcm1 and this binding factor to target gene promoters to ensure correct and 
timely gene expression.      
3.3 Future Directions 
 
 My data suggests several additional experiments that will lead to a better understanding 
of Hcm1 activation.  First, it will be important to integrate other unique and informative 
combinations of phosphosite mutations at the HCM1 genomic locus and repeat the benomyl 
sensitivity screen.  This will lead to a better understanding of which Cdk consensus sites are 
needed for Hcm1 stimulation.  To test the proposed model of overall charge being necessary for 
Hcm1 activation (Figure 9B), I will generate several phosphomutants that each has a different 
combination of 4 phosphosite mutations.  If the phosphorylation of each cluster, regardless of the 
4 specific sites it contains, results in activation of Hcm1, it would validate the overall charge 
model of phosphoregulation.  To investigate the model of site-specific phosphorylation (Figure 
9A), I will mutate individual sites within the 3A and 4A phosphomutants.  If I find a single site 
among those mutated in the 3A phosphomutant, and a single site among those mutated in the 4A 
phosphomutant, that are required for activity, this would support the model that there are specific 
sites in each cluster that are required for Hcm1 phosphoregulation.  Additionally, we will need to 
determine if the benomyl sensitivity of these Hcm1 phosphomutants correlates with the 
decreased binding of Hcm1 to target promoters and decreased expression of target genes, similar 
to what we observed in hcm1Δ, hcm1-15A, and hcm1-8C strains.  Finally, in order to understand 
the molecular consequences of Hcm1 phosphoregulation, it will be important to identify other 
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proteins that bind to Hcm1 target gene promoters in both the wild type and phosphomutant-
expressing cells.  This could confirm our prediction that Cdk phosphorylation stimulates Hcm1 
activity by promoting interaction with another protein required for its DNA binding. 
 In conclusion, the human homologue of Hcm1, FoxM1, is overexpressed in a number of 
human cancers.  Understanding the function and control of Hcm1 in yeast could lead to a better 
understanding of the regulation of FoxM1 and other transcription factors with similar TAD 
domains, as the mechanisms of phosphoregulation by Cdk1 could be conserved in other systems.  
In fact, many similarities in regulation have already been found between Hcm1 and FoxM1.  
Understanding the mechanisms of cell cycle-regulation in yeast will provide valuable 
information about such regulation and breakdowns in control in humans.  This will better aide 
the investigation of many types of cancers.  
4. Methods 
 
Cloning  
 To construct the HCM1 expression plasmid, 3V5-tagged HCM1 and 500 base pairs of its 
promoter were amplified by polymerase-chain reaction (PCR) using a proofreading polymerase 
and cloned into a pGEM-T Easy cloning vector.  The correct sequence was confirmed by 
sequencing.  The plasmid was then digested and the fragment containing HCM1 and its promoter 
was gel-purified.  This fragment was sub-cloned into the pRS313 vector and confirmed by 
sequencing.  This plasmid expressing 3V5-tagged HCM1 from its endogenous promoter was 
used for the randomized mutagenesis strategy described in the results section.     
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Benomyl Screen Assay 
 
 In this assay, cells were grown in rich media with 2% dextrose until they reached mid-log 
phase.  Five-fold dilutions were then plated on rich media plates (YPD) with 2% dextrose and 
0µg/mL, 15µg/mL or 20µg/mL of the spindle poison benomyl.  These plates were incubated at 
30°C and were removed when colony sizes were approximately equal. 
 
Western Blotting  
 
 First, equal optical densities of cells were collected and pelleted.  Cells were lysed in pre-
heated SDS sample buffer (50 mM Tris pH 7.5, 5 mM EDTA, 5% SDS, 10% glycerol, 0.5% β-
mercaptoethanol, bromophenol blue, 1 mg/mL leupeptin, 1 mg/mL bestatin, 1 mM benzamidine, 
1 mg/mL pepstatin A, 17 mg/mL PMSF, 5 mM sodium fluoride, 80 mM β-glycerophosphate and 
1 mM sodium orthovanadate) and heated at 95°C for 5 minutes.  Next, glass beads were added 
and samples were bead-beat with a Mini-BeadBeater-96 for 3 minutes.  The lysates were then 
clarified by centrifugation.  The extracts obtained were run on 10% SDS–polyacrylamide gels 
and were transferred to nitrocellulose membranes.  The Western blots were incubated overnight 
at 4°C in primary antibody, followed by secondary antibody for 30min at room temperature the 
following day.  Primary antibodies were diluted in 4% non-fat milk/PBS and were against V5 
and Cdc28 (Cdk1). Blots were visualized using SuperSignal West Femto Chemiluminescent 
Substrate on film. 
 
Strain Construction to integrate Hcm1 Phosphosite Mutations    
 Plasmids A, D, E, J and G were chosen from the primary screen as informative 
combinations.  To integrate these mutants into the genome, I utilized strains that had been 
previously generated in the lab that contain either wild-type HCM1 tagged with GFP and marked 
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with the KanMX selection cassette (YJB598), or HCM1-8C that is tagged with GFP and marked 
with KanMX (YJB600). I then used homologous recombination to replace the C-terminus of 
HCM1 in these strains with different wild-type or phosphomutant sequences, along with a 3V5 
tag and the HIS3 marker. Using this strategy I converted wild-type sites in YJB598 to 
phosphomutant sites (mutants A, E, J, G), or reverted the phosphomutant sites in YJB600 to 
wild-type sites (mutant D). The newly synthesized strains were named according to the number 
of phosphosite mutations the allele contained in its C-terminus.  Table 3 summarizes this 
information and the genotypes for the strains are in Supplemental Table 1.   
 These strains were verified in a 4-step process.  They were first selected for their ability 
to grow on plates lacking histidine and their inability to grow on plates containing KanMX (since 
the KanMX cassette was replaced by the HIS3 cassette upon recombination).  Next, I confirmed 
that the 3V5-tag and HIS3 cassette were correctly integrated at the HCM1 locus using PCR. 
Then, the C-terminal sites of each strain were PCR amplified with a proofreading polymerase 
and sequenced to confirm the integration of the desired phosphosite mutations.  Finally, protein 
expression was verified by Western blot, as described above.     
Table 3: Construction of Strains expressing Hcm1 mutants from the genomic locus. The 
strains were named according to the number of phosphosite mutations each contained. Indicated 
sequences were amplified and transformed into the strains indicated.  
Strain Name Specific Sequence Amplified Strain Transformed with 
PCR Product 
Hcm1C-5A T460A, S471A, T479A, T486A, S496A YJB598 
Hcm1C-3A T460, S471, T479, T486, S496 YJB600 
Hcm1C-4A T460A, S471A, T479A, T486A YJB598 
Hcm1C-2A T460A, S471A YJB598 
Hcm1C-1A S496A YJB598 
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6. Supplemental Table 
 
Table S1: Yeast Strains    
Name Genotype Figure 
YBL176 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 HCM1-3HA-HIS3 2B, 3 
YBL177 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-15A-3HA-HIS3 2B-C, 
3 
hcm1Δ MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx 2C, 3, 
7, 8  
YHA38 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-3N-3HA-HIS3 2D, 3 
YHA65 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-8C-3HA-HIS3 2D, 3 
YKP8 MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-3V5-HIS3 5, 6 
YKP10 MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-HCM1-3V5-HIS3 5, 6 
YKP16 MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313- hcm1-11C-3V5-HIS3 5, 6 
YKP17 MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313- hcm1-8C-3V5-HIS3 5, 6 
YKPA MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313- hcm1-T460A S471A 
T479A T486A S496A-3V5-HIS3 
5, 6 
YKPB MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1-S350A S369A 
S387A T428A T440A T447A T479A T486A S496-3V5-HIS3 
5, 6 
YKPC MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1-S350A S369A 
S387A T428A T440A T479A T486A S496-3V5-HIS3 
5, 6 
YKPD MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1-T428A T440A 
T447A-3V5-HIS3 
5, 6 
YKPE MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1-T460A S471A 
T479A T486A-3V5-HIS3 
5, 6 
YKPF MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1- S350A S369A 
S387A T428A-3V5-HIS3 
5, 6 
YKPG MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1-S496A-3V5-HIS3 5, 6 
YKPH MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1- S350A S369A 
S387A S496A-3V5-HIS3 
5, 6 
YKPI MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313-hcm1- S350A S369A 
S387A-3V5-HIS3 
5, 6 
YKPJ MATa his3∆1 ura3∆0 leu2∆0 met15∆0 hcm1∆::KanMx + pRS313- hcm1- T460A S471A-
3V5-HIS3 
5, 6 
YBL192 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 HCM1-3V5-KanMx 7, 8 
YBL193 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-15A-3V5-KanMx 7, 8 
YBL398 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-8C-3V5-KanMX 7, 8 
YJB598 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 HCM1-GFP-KanMX 7, 8 
YJB600 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-8C-GFP-KanMX 7, 8 
YKP11 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-T460A S471A T479A T486A S496A-3V5-HIS3 7, 8 
YKP12 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-T428A T440A T447A-3V5-HIS3 7, 8 
YKP13 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1-T460A S471A T479A T486A-3V5-HIS3 7, 8 
YKP14 MATa ura3∆0 leu2∆0 his3∆0 met15∆0 hcm1- T460A S471A-3V5-HIS3 7, 8 
YKP15 MATa ura3∆0 leu2∆0 his3∆0 met15∆ hcm1-S496A-3V5-HIS3 7, 8 
 
